QuiVad
My list

Home / Funds / GSA Capital Partners LLP

GSA Capital Partners LLP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSinceFiling
Valneva SEFrance1.21%July 21, 2026AMF
Oncopeptides ABSweden1.19%September 22, 2026
Tobii ABSweden1.19%September 10, 2026
Tessellis SPAItaly1.18%August 24, 2026
Powercell Sweden AB (publ)Sweden1.00%September 11, 2026
RaySearch Laboratories AB (publ)Sweden1.00%September 14, 2026
Hexagon CompositesNorway0.99%August 24, 2026
2020 BulkersNorway0.94%September 23, 2026
Hilbert Group AB (publ)Sweden0.91%September 21, 2026
OssDsign ABSweden0.81%June 1, 2026
Trevi - Finanziaria Industriale SPAItaly0.61%August 24, 2026
BFF Bank SPAItaly0.60%September 8, 2026
Hansa Biopharma ABSweden0.60%September 9, 2026
Solutions 30 SEFrance0.60%September 11, 2026
Elliptic Laboratories ASANorway0.51%August 26, 2026
Smart Eye Aktiebolag (publ)Sweden0.51%August 27, 2026
EuroAPIFrance0.50%September 14, 2026
NSI N.V.Netherlands0.50%September 18, 2026
Nobia ABSweden0.50%June 12, 2026
Pharming Group N.V.Netherlands0.50%September 23, 2026
Tubacex, S.A.Spain0.50%July 10, 2026

Follow by RSS

Get the moves on GSA Capital Partners LLP by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

4503 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
March 27, 2026Powercell Sweden AB (publ)Sweden0.60%
March 26, 2026Desert Control ASNorway0.51%April 21, 2026
March 23, 2026Nyesa Valores Corporacion, S.A.Spain0.50%
March 19, 2026RaySearch Laboratories AB (publ)Sweden0.50%
March 18, 2026Hexagon CompositesNorway2.01%March 20, 2026
March 18, 2026Hansa Biopharma ABSweden0.60%
March 18, 2026Dicot Pharma ABSweden0.58%
March 16, 2026Solutions 30 SEFrance0.70%AMF
March 12, 2026Hexagon CompositesNorway1.90%March 13, 2026
March 12, 2026Tessellis SPAItaly1.50%
March 12, 2026Dicot Pharma ABSweden0.69%
March 9, 2026Hexagon CompositesNorway1.80%March 10, 2026
March 9, 2026Dicot Pharma ABSweden0.78%
March 6, 2026Powercell Sweden AB (publ)Sweden0.51%
March 6, 2026Alfen N.V.Netherlands0.48%
March 5, 2026Tobii ABSweden1.60%
March 4, 2026Hexagon CompositesNorway1.72%March 9, 2026
March 4, 2026Dicot Pharma ABSweden0.80%
March 4, 2026Alfen N.V.Netherlands0.55%
March 4, 2026Salmon Evolution ASANorway0.50%May 4, 2026
March 3, 2026OssDsign ABSweden0.60%
February 27, 2026Alfen N.V.Netherlands0.69%
February 25, 2026Hexagon CompositesNorway1.60%March 2, 2026
February 25, 2026BICO Group ABSweden0.50%
February 25, 2026Hansa Biopharma ABSweden0.50%
February 24, 2026Alfen N.V.Netherlands0.79%
February 24, 2026Dicot Pharma ABSweden0.70%
February 20, 2026Hexagon CompositesNorway1.52%February 23, 2026
February 20, 2026Tobii ABSweden1.51%
February 20, 2026Solutions 30 SEFrance0.61%AMF
February 19, 2026Alfen N.V.Netherlands0.87%
February 18, 2026EkinopsFrance0.50%August 6, 2026
February 17, 2026MilDef Group ABSweden0.50%
February 16, 2026Dicot Pharma ABSweden0.61%
February 16, 2026OssDsign ABSweden0.50%
February 13, 2026Hexagon CompositesNorway1.42%February 16, 2026
February 13, 2026Tobii ABSweden1.40%
February 13, 2026Alfen N.V.Netherlands0.96%
February 11, 2026Hansa Biopharma ABSweden0.50%
February 10, 2026Hexagon CompositesNorway1.32%February 11, 2026
February 10, 2026Tobii ABSweden1.31%
February 6, 2026Valneva SEFrance0.60%May 6, 2026
February 6, 2026Dicot Pharma ABSweden0.51%
February 5, 2026Hexagon CompositesNorway1.23%February 9, 2026
February 2, 2026Hexagon CompositesNorway1.11%February 3, 2026
January 29, 2026Valneva SEFrance0.59%May 6, 2026
January 21, 2026Hexagon CompositesNorway1.01%January 22, 2026
January 16, 2026Alfen N.V.Netherlands1.09%
January 14, 2026Hexagon CompositesNorway0.91%January 15, 2026
January 13, 2026Tobii ABSweden1.22%

The AMF column opens the filing the fund itself lodged, on the regulator own site.

Download 4503 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners LLP, data as at September 23, 2026, https://www.quivad.com/detenteur/gsa-capital-partners-llp?page=5